Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2017-09-26 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
2017年第一次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, procedures, and results of a 2017 first extraordinary general meeting (临时股东大会) of shareholders of a company. It details the legality of the meeting's call, attendance, voting procedures, and results, including election of board members and supervisors. The document is not a financial report, earnings release, or management discussion, but rather a formal legal opinion on the shareholder meeting and its voting outcomes. This type of document corresponds to Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting. The document length is about 5,199 characters, which is substantive and not a mere announcement or notice. Therefore, the classification is DVA with high confidence.
2017-09-26 Chinese
关于高级管理人员辞职公告
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the resignation of a senior management member, specifically the vice general manager Liu Feifei. It includes details about the resignation date, the reason, and the impact on the company. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the resignation notice. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2017-09-20 Chinese
关于召开2017年第一次临时股东大会提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2017 first extraordinary general meeting (临时股东大会) of shareholders for 葵花药业集团股份有限公司. It includes information about the meeting date, location, agenda items (mainly election of board members and supervisors), voting procedures (including cumulative voting and network voting), registration details, and proxy forms. There is no financial data, earnings information, or audit content. The document is not a report itself but an announcement and notice about the meeting and voting process. It is not a voting results declaration since it does not provide results, only the meeting notice and related procedural information. Therefore, the document fits best into the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to the Annual or Extraordinary General Meeting, including meeting notices and agendas.
2017-09-18 Chinese
关于公司董事、监事减持公司股份计划实施进展公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the implementation progress of a share reduction plan by company directors and supervisors. It details the number of shares held before and after the reduction, the reduction methods, and confirms that the reduction is within the planned limits. There is no financial report, earnings data, or management discussion. The content focuses on insider share transactions by company directors and executives. Therefore, this document fits the category of Director's Dealing (DIRS). The document length is 2367 characters, which is consistent with a detailed insider transaction announcement rather than a full report or regulatory filing.
2017-09-13 Chinese
关于召开2017年第一次临时股东大会的通知
Board/Management Information Classification · 95% confidence The document is a detailed notice about convening the 2017 first extraordinary general meeting of shareholders for a company, including information on meeting time, location, agenda items, voting procedures, and proxy forms. The agenda focuses on the election of board members and supervisors, which is a management and board-related matter. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal announcement and detailed instructions for a shareholder meeting. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management. The document length is sufficient and contains substantive content about board elections, not just a brief announcement or proxy solicitation. Therefore, the best classification is MANG with high confidence.
2017-09-06 Chinese
第二届董事会第四十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 41st meeting of the second board of directors of the company 葵花药业集团股份有限公司. It details the approval of an investment project and includes voting results. There is no financial data, no mention of annual or quarterly reports, no audit information, and no indication of a shareholder meeting or voting results related to general meetings. The document is clearly about board decisions and management resolutions. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA. Confidence is high due to clear keywords like '董事会会议决议公告' (Board meeting resolution announcement) and the content focusing on board resolutions.
2017-08-29 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.